Method for treating breast cancer and ovarian cancer
AssigneeTakeda Pharmaceutical Company Limited
InventorJames W. Darnowski
Life of this patent
Estimating the term…
Abstract
The present invention relates to a method for the prevention or treatment of certain breast cancers or ovarian cancer comprising administering to a patient in need thereof of a therapeutically effective amount of a 17,20-lyase inhibitor, wherein the breast cancer or ovarian cancer is estrogen receptor (ER) negative.
Claims17
A method for the prevention or treatment of breast cancer or ovarian cancer comprising administering to a patient in need thereof a therapeutically effective amount of a 17,20-lyase inhibitor, wherein the breast cancer or ovarian cancer is ER negative.
A method for the prevention or treatment of breast cancer comprising administering to a patient in need thereof a therapeutically effective amount of a 17,20-lyase inhibitor, wherein the breast cancer is ER negative.
A method for the prevention or treatment of ovarian cancer comprising administering to a patient in need thereof a therapeutically effective amount of a 17,20-lyase inhibitor, wherein the ovarian cancer is ER negative.
Dependencies are inferred from the claim text.